HIV prevention meets family planning: a new strategy for young women in kenya
NCT ID NCT04666792
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 35 times
Summary
This study looked at whether offering HIV prevention services, including PrEP medication, in family planning clinics could help more young women in Kenya get tested for HIV and start prevention. Over 25,000 sexually active, HIV-negative women aged 15-24 were included. The goal was to see if integrating these services into routine care is practical and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kenyatta National Hospital
Kisumu, Kenya
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PrEP (emtricitabine/tenofovir disoproxil fumarate)
What this could lead to
If successful, this approach could make it easier for young women to get HIV prevention services during routine family planning visits, reducing new infections.
What could go wrong
This is an implementation study, not a test of PrEP's effectiveness. Results may depend on local resources and may not apply to other settings. Adherence and follow-up can be challenging.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.